Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis
Metrics: PDF 1902 views | HTML 2097 views | ?
Chi-Ruei Huang1,2, Chung-Ta Lee3, Kwang-Yu Chang4,5, Wen-Chang Chang2, Yao-Wen Liu6, Jenq-Chang Lee7, Ben-Kuen Chen1,8,9
1Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Taiwan, ROC
2Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taiwan, ROC
3Department of Pathology, National Cheng Kung University Hospital, Taiwan, ROC
4National Institute of Cancer Research, National Health Research Institutes, Taiwan, ROC
5Division of Hematology/Oncology, Department of Internal Medicine; National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan, ROC
6Department of Pathology, Kuo General Hospital, Taiwan, ROC
7Department of Surgery, National Cheng Kung University Hospital, Taiwan, ROC
8Department of Pharmacology, College of Medicine, National Cheng Kung University, Taiwan, ROC
9Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taiwan, ROC
Ben-Kuen Chen e-mail: [email protected]
Keywords: metastasis, ARNT, oncogene, ROS
Received: October 15, 2014 Accepted: February 25, 2015 Published: March 20, 2015
The aryl hydrocarbon receptor nuclear translocator (ARNT) is broadly involved in regulating tumorigenesis by inducing genes that are involved in tumor growth and angiogenesis. Tumorigenesis usually involves normoxic conditions. However, the role of ARNT in tumor metastasis during normoxia remains unclear. Here, we demonstrate that ARNT protein levels were decreased in late-stage human colorectal cancer using immunohistochemical analysis. Down-regulation of ARNT protein promoted cancer cell migration and invasion, which was mediated by activation of the fibronectin/integrin β1/FAK signaling axis. In addition, the enhancement of migration and invasion in ANRT knockdown cells was blocked when ARNT was restored in the cells. In xenografts in severe combined immunodeficiency mice, tumor growth was significantly inhibited in the ARNT-knockdown condition. However, the tail-vein injection animal model revealed that the depletion of ARNT-induced metastatic lung colonies was further enhanced when ARNT expression was recovered post-injection. Interestingly, chemotherapeutic drugs inhibited ARNT expression and promoted the invasion of residual tumor cells. These results suggest that ARNT may play a positive role during tumor growth (either in early-stage tumor growth or in organ metastases), but plays a negative role in tumor migration and invasion. Therefore, the efficiency of ARNT-targeted therapy during different cancer stages should be carefully evaluated.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.